The global benign prostatic hyperplasia treatment market is estimated to witness significant growth during the forecast period. The rising demand for innovative treatment options for benign prostatic hyperplasia is driving the market growth. 5 alpha-reductase inhibitors are the new innovation in benign prostatic hyperplasia drug treatment market. This helps to treat the lower urinary tract.